Previous close | 15.86 |
Open | 15.83 |
Bid | 15.80 x 400 |
Ask | 15.89 x 300 |
Day's range | 15.42 - 16.01 |
52-week range | 8.92 - 24.50 |
Volume | |
Avg. volume | 370,220 |
Market cap | 718.458M |
Beta (5Y monthly) | 1.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.52 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 23.13 |
BioLife Solutions Inc (NASDAQ:BLFS) Chief Marketing Officer Todd Berard has sold 10,000 shares of the company on April 15, 2024, according to a recent SEC Filing.
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") and the broader biopharma markets, today announced that it has completed the divestiture of its wholly owned subsidiary Global Cooling, Inc. ("GCI" or "Stirling").
BioLife Solutions, Inc. ( NASDAQ:BLFS ) shareholders should be happy to see the share price up 14% in the last quarter...